3D model is for representation purpose only.
.
.
FYPWMKG | 1H-Imidazole-2-carboxamide, N-[1-(3-aminopropyl)-5-[[[5-[[[4-[[2-[[[5-[[[5-[[[5-[[[3-[[3-(dimethylamino)propyl]amino]-3-oxopropyl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]amino]carbonyl]-1-methyl-1H-imidazol-4-yl]amino]-4-oxobutyl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]amino]carbonyl]-1H-pyrrol-3-yl]-1-methyl-4-[[(1-methyl-1H-imidazol-2-yl)carbonyl]amino]- |
Identification | |
---|---|
ConjuPepDB ID | cpd01420 |
Smiles | |
Molecular weight | 2217.04 |
Molecular formula | C108H136N32O19S |
Chemical name | Peptide information |
Sequence (one letter) | FYPWMKG |
Length | 7 |
Peptide name | N/A |
External ID | |
---|---|
CAS number | 619329-60-1 |
Other information | |
---|---|
Application | Synthesis |
Additional function | DNA binding |
Pharmacological class | other |
Conjugate type | amide |
Linker | no |
Small molecule | 1H-Imidazole-2-carboxamide, N-[1-(3-aminopropyl)-5-[[[5-[[[4-[[2-[[[5-[[[5-[[[5-[[[3-[[3-(dimethylamino)propyl]amino]-3-oxopropyl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]amino]carbonyl]-1-methyl-1H-imidazol-4-yl]amino]-4-oxobutyl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]amino]carbonyl]-1H-pyrrol-3-yl]-1-methyl-4-[[(1-methyl-1H-imidazol-2-yl)carbonyl]amino]- |
Small molecule CAS | 933050-96-5 |
Structure method | X-ray crystallography |
Calculated properties | |
---|---|
LogP | -0.54075 |
Rotatable bonds | 56 |
H bond donor | 20 |
H bond acceptor | 24 |
Polar surface area (PSA) | 658.40000 |
Citations | |||||
---|---|---|---|---|---|
ID | Title | Year | Authors | Journal | DOI |
Toward Artificial Developmental Regulators | 2003 | Arndt, Hans-Dieter; Hauschild, Karl E.; Sullivan, David P.; Lake, Kara; Dervan, Peter B.; Ansari, Aseem Z. | Journal of the American Chemical Society |